Amicogen, Inc., founded in 2000, is a South Korean biotechnology company specializing in the development, production, and marketing of specialty enzymes and functional food ingredients. The company utilizes advanced DNA evolution technology and focuses on healthcare products, bio-based materials, and sustainable solutions. Amicogen operates globally, with production facilities and partnerships in Asia, America, and Europe. Its key products include collagen peptides, N-acetylglucosamine (NAG), and enzyme-based healthcare supplements. The company emphasizes research and development, with about 30% of its employees dedicated to R&D.